These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 7955179)

  • 1. Plasma concentration of cross-linked fibrin degradation product (D-dimer) and the risk of future myocardial infarction among apparently healthy men.
    Ridker PM; Hennekens CH; Cerskus A; Stampfer MJ
    Circulation; 1994 Nov; 90(5):2236-40. PubMed ID: 7955179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue plasminogen activator antigen and D-dimer as markers for atherothrombotic risk among healthy postmenopausal women.
    Pradhan AD; LaCroix AZ; Langer RD; Trevisan M; Lewis CE; Hsia JA; Oberman A; Kotchen JM; Ridker PM
    Circulation; 2004 Jul; 110(3):292-300. PubMed ID: 15238458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validity of enzyme-linked immunosorbent assays of cross-linked fibrin degradation products as a measure of clot lysis.
    Eisenberg PR; Jaffe AS; Stump DC; Collen D; Bovill EG
    Circulation; 1990 Oct; 82(4):1159-68. PubMed ID: 2119264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endogenous tissue-type plasminogen activator and risk of myocardial infarction.
    Ridker PM; Vaughan DE; Stampfer MJ; Manson JE; Hennekens CH
    Lancet; 1993 May; 341(8854):1165-8. PubMed ID: 8098074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrinolytic activation markers predict myocardial infarction in the elderly. The Cardiovascular Health Study.
    Cushman M; Lemaitre RN; Kuller LH; Psaty BM; Macy EM; Sharrett AR; Tracy RP
    Arterioscler Thromb Vasc Biol; 1999 Mar; 19(3):493-8. PubMed ID: 10073948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men.
    Ridker PM; Hennekens CH; Roitman-Johnson B; Stampfer MJ; Allen J
    Lancet; 1998 Jan; 351(9096):88-92. PubMed ID: 9439492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-reactive protein, fibrin D-dimer, and incident ischemic heart disease in the Speedwell study: are inflammation and fibrin turnover linked in pathogenesis?
    Lowe GD; Yarnell JW; Rumley A; Bainton D; Sweetnam PM
    Arterioscler Thromb Vasc Biol; 2001 Apr; 21(4):603-10. PubMed ID: 11304479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. D-Dimer Predicts Long-Term Cause-Specific Mortality, Cardiovascular Events, and Cancer in Patients With Stable Coronary Heart Disease: LIPID Study.
    Simes J; Robledo KP; White HD; Espinoza D; Stewart RA; Sullivan DR; Zeller T; Hague W; Nestel PJ; Glasziou PP; Keech AC; Elliott J; Blankenberg S; Tonkin AM;
    Circulation; 2018 Aug; 138(7):712-723. PubMed ID: 29367425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction.
    Stampfer MJ; Krauss RM; Ma J; Blanche PJ; Holl LG; Sacks FM; Hennekens CH
    JAMA; 1996 Sep; 276(11):882-8. PubMed ID: 8782637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haemostatic factors and prediction of ischaemic heart disease and stroke in claudicants.
    Smith FB; Rumley A; Lee AJ; Leng GC; Fowkes FG; Lowe GD
    Br J Haematol; 1998 Mar; 100(4):758-63. PubMed ID: 9531345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective evaluation of the relationship between C-reactive protein, D-dimer and progression of peripheral arterial disease.
    Musicant SE; Taylor LM; Peters D; Schuff RA; Urankar R; Landry GJ; Moneta GL
    J Vasc Surg; 2006 Apr; 43(4):772-80; discussion 780. PubMed ID: 16616235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. D-dimer and platelet aggregability are related to thrombotic events in patients with peripheral arterial occlusive disease.
    Komarov A; Panchenko E; Dobrovolsky A; Karpov Y; Deev A; Titaeva E; Davletov K; Eshkeeva A; Markova L
    Eur Heart J; 2002 Aug; 23(16):1309-16. PubMed ID: 12175668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. D-dimers in relation to the severity of arteriosclerosis in patients with stable angina pectoris after myocardial infarction.
    Tataru MC; Heinrich J; Junker R; Schulte H; von Eckardstein A; Assmann G; Koehler E
    Eur Heart J; 1999 Oct; 20(20):1493-502. PubMed ID: 10493848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective study of endogenous tissue plasminogen activator and risk of stroke.
    Ridker PM; Hennekens CH; Stampfer MJ; Manson JE; Vaughan DE
    Lancet; 1994 Apr; 343(8903):940-3. PubMed ID: 7909008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective study of fibrinogen and risk of myocardial infarction in the Physicians' Health Study.
    Ma J; Hennekens CH; Ridker PM; Stampfer MJ
    J Am Coll Cardiol; 1999 Apr; 33(5):1347-52. PubMed ID: 10193737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated serum D dimer: a degradation product of cross-linked fibrin (XDP) after intravenous streptokinase during acute myocardial infarction.
    Lew AS; Berberian L; Cercek B; Lee S; Shah PK; Ganz W
    J Am Coll Cardiol; 1986 Jun; 7(6):1320-4. PubMed ID: 3711489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased markers of thrombogenesis in chronic atrial fibrillation: effects of warfarin treatment.
    Lip GY; Lowe GD; Rumley A; Dunn FG
    Br Heart J; 1995 Jun; 73(6):527-33. PubMed ID: 7626351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-6, fibrin D-dimer, and coagulation factors VII and XIIa in prediction of coronary heart disease.
    Lowe GD; Rumley A; McMahon AD; Ford I; O'Reilly DS; Packard CJ;
    Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1529-34. PubMed ID: 15205218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma concentration of soluble vascular cell adhesion molecule-1 and subsequent cardiovascular risk.
    de Lemos JA; Hennekens CH; Ridker PM
    J Am Coll Cardiol; 2000 Aug; 36(2):423-6. PubMed ID: 10933352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitation of venous clot lysis with the D-dimer immunoassay during fibrinolytic therapy requires correction for soluble fibrin degradation.
    Brenner B; Francis CW; Totterman S; Kessler CM; Rao AK; Rubin R; Kwaan HC; Gabriel KR; Marder VJ
    Circulation; 1990 Jun; 81(6):1818-25. PubMed ID: 2111742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.